РАССТРОЙСТВА СОКРАТИМОСТИ В ГЛАДКО — МЫШЕЧНОЙ ТКАНИ ЖЕЛУДКА ИНДУЦИРОВАННЫЕ СВИНЦОМ

1. Abayasekara DR, Jones PM, Persaud SJ, Michael AE, Flint AP. Prostaglandin F2 alpha activates protein kinase C in human ovarian cells. Mol Cell Endocrinol 1993; 91 : 51-57. 2. Canfield RL, Henderson CRJr, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003; 348 : 1517-1526. 3. Chai SS, Webb RC. Effects of lead on vascular reactivity. Environ Health Perspect 1988; 78: 85–89. 4. Chang WC, Chang CC. Involvement of the epidermal growth factor receptor in Pb2+ -induced activation of cPLA₂/COX-2 genes and PGE₂ production in vascular smooth muscle cells. Toxicology 2011; 279 : 45-53. 5. Costa M, Brookes SJ. Тhe enteric nervous system. Am J Gastroenterol 1994; 89:129-137. 6. Dannhardt G, Ulbrich H. In-vitro test system for the evaluation of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) inhibitors based on a single HPLC run with UV detection using bovine aortic coronary endothelial cells (BAECs). Inflamm Res 2001; 50 : 262-269. 7. Dorman RV, Freeman, EJ. Lead-dependent effects on arachidonic acid accumulation and the proliferation of vascular smooth muscle. Journal of Biochemical and Molecular Toxicology 2002; 16 : 245–253. 8. Grider JR. Neurotransmitters mediating the intestinal peristaltic reflex in the mouse. J PharmacolExpTher 2003; 307 : 460–467. 9. Korrick SA, Hunter DJ, Rotnitzky A. Lead and hypertension in a sample of middle-aged women. Am J Public Health 1999; 89 : 330–335. 10. Le-Feng Z, Shuang-Qing P, Sheng W. Decreased aortic contractile reaction to 5-hydroxytryptamine in rats with long-term hypertension induced by lead (Pb2+) exposure. Toxicology Letters 2009; 186 : 78–83. 11. Rao P, Knaus EE. Evolution of NonsteroidalAntiInflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond. J Pharmacy & Pharmaceutical Sci 2008; 11 : 81-110. 12. Richardt G , Federolf G, Habermann E. Affinity of heavy metal ions to intracellular Ca2+-binding proteins. Biochemical Pharmacology 1986; 35 : 1331- 1335. 13. Santos MRV, Marchioro M, Antoniolli AR. Lead effects on no-adrenergic non-cholinergic relaxations in rat gastric fundus. Toxicology in Vitro 2006; 20 : 38-42. 14. Scelfo GM, Flegal AR. Lead in calcium supplements. Environ Health Perspect 2000; 108 : 309- 313. 15. Shiri R, Ansari M, Ranta M, Falah-Hassani K. Lead poisoning and recurrent abdominal pain. Ind Health 2007; 45 : 494-496. 16. Sopi RB, Bislimi K, Halili F, Sopjani M, Neziri B, Jakupi M. Lead acetate induces epithelium-dependent contraction of airway smooth muscle. J International Environmental Application & Science 2009; 4 : 146-151. 17. Sung KP, Schwartz J. Low-Level Lead Exposure, Metabolic Syndrome, and Heart Rate Variability: The VA Normative Aging Study. Environ Health Perspect 2006; 114 : 1718-1724. 18. Tomera JF, Harakal C. Mercury and lead-induced contraction of aortic smooth muscle in vitro. Arch IntPharmacodynTher 1986; 283 : 295-302. 19. Tomsig JL, Suszkiw JB. Permeation of Pb2 through calcium channels: Fura-2 measurements of voltage- and dihydrophyridine-sensitve Pb2 entry in isolated bovine chromaffin cells. BiochimBiophysActa 1991; 1069 : 197-200. 20. Tsao D-A, Yu H-S, Cheng J-T. The change of β-adrenergic system in lead-induced hypertension. ToxicolApplPharmacol 2000; 163:127-133. 21. Valencia-Hernandez I, Bobadilla-Lugo RA, Castillo-Henkel C. Differences of lead-induced contraction in rat and rabbit aorta. Proc West PharmacolSoc 2001; 44 : 167-168. 22. Vaziri ND, Sica DA. Lead-induced hypertension: Role of oxidative stress. CurrHypertens Rep 2004; 6 : 314-320. 23. Wasserman GA, Factor-Litvak P, Liu X. The relationship between blood lead, bone lead and child intelligence. NeuropsycholDevCogn C Child Neuropsychol 2003; 9 : 22-34. 24. Watts SW, Chai S, Webb RC. Lead acetateinduced contraction in rabbit mesenteric artery: Interaction with calcium and protein kinase C. Toxicology 1995; 99 : 55-65. 25. Weaver VM, Lee BK, Todd AC. Associations of patella lead and other lead biomarkers with renal function in lead workers. J Occup Environ Med 2005; 47 : 235-243. 26. Wedeen RP. Bone lead, hypertension, and lead nephropathy. Environ Health Perspect 1988; 78 : 57- 60. 27. Yu L, Wu WK, Li ZJ, Li HT, Wu YC, Cho, CH. Prostaglandin E (2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells. Int J Cancer 2009; 125 : 2540-2546.